Skip to main content
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. — Investor Relations & Filings

Ticker · SCNI ISIN · US09073Q3039 US Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2024-06-14 Report Publication Anno…
Country US United States of America
Listing US SCNI

About Scinai Immunotherapeutics Ltd.

https://www.scinai.com/

Scinai Immunotherapeutics Ltd. is a clinical-stage biopharmaceutical company operating through two complementary business units. Its internal research and development division focuses on developing innovative biological products for inflammation and immunology (I&I), targeting autoimmune and infectious diseases. The core of its therapeutic pipeline is a platform of Alpaca-derived nanosized antibodies (NanoAbs or VHH-antibodies), developed for conditions such as psoriasis and asthma. The company's second unit, Scinai Bioservices, is a Contract Development and Manufacturing Organization (CDMO). It provides end-to-end services to biotech companies, supporting drug development from early research and process development through to cGMP-compliant manufacturing for clinical trials up to Phase 3.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Report Publication Announcement Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes an explanatory note stating that an updated presentation about the company's business is furnished as Exhibit 99.1. The document itself is short (2097 characters) and primarily serves to announce the availability of the presentation rather than containing the presentation or detailed financial data itself. According to the 'Menu vs Meal' rule, such a document is an announcement of a report (the presentation) rather than the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2024-06-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about a letter of intent from the European Investment Bank regarding loan conversion into equity. The document is short (2109 characters) and primarily serves to furnish a press release rather than detailed financial data or comprehensive reporting. It does not contain full financial statements or detailed analysis typical of annual or interim reports. It also does not fit into categories like management changes, earnings releases, or legal proceedings. Given the short length and nature of the content, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2024-06-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed pursuant to the Securities Exchange Act of 1934. It includes a press release about regaining compliance with Nasdaq listing rules and ongoing discussions with the European Investment Bank regarding loan conversion to equity. The document is short (2226 characters) and primarily serves to furnish a press release rather than provide detailed financial data or comprehensive reporting. It does not contain financial statements or substantive financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2024-06-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about a Nasdaq staff determination letter regarding shareholders' equity listing requirements and a hearing to present a plan for regaining compliance. The document is relatively short (2058 characters) and primarily furnishes a press release as Exhibit 99.1. There are no detailed financial statements or substantive financial data presented. The document serves as a regulatory update and announcement rather than a full financial report or earnings release. According to the rules, such filings that do not fit other categories and are regulatory announcements fall under Regulatory Filings (RNS).
2024-05-28 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 filing, which is a prospectus supplement related to securities offerings, specifically concerning American Depositary Shares (ADS) and their ratio to underlying shares. It details the terms of the deposit agreement, rights, and obligations related to the ADS, and changes effective May 21, 2024. This type of filing is related to capital markets and financing activities, not an annual report, earnings release, or other financial report. It is not a report publication announcement or a certification. The document is a detailed legal and financial disclosure about the capital structure and depositary shares, fitting the Capital/Financing Update category.
2024-05-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Report Publication Announcement Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references the announcement of the publishing of FY 2023 financial statements and the filing of the Annual Report on Form 20-F, but the document itself is a brief report furnishing a press release about that event. The document length is only 2020 characters, indicating it is short and primarily an announcement rather than the full annual report. According to the 'Menu vs Meal' rule, such short documents announcing the publication of a report should be classified as Report Publication Announcement (RPA). Therefore, this document is best classified as RPA with high confidence.
2024-05-15 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.